A generalized epilepsy network derived from brain abnormalities and deep brain stimulation
- PMID: 40128186
- PMCID: PMC11933423
- DOI: 10.1038/s41467-025-57392-7
A generalized epilepsy network derived from brain abnormalities and deep brain stimulation
Abstract
Idiopathic generalized epilepsy (IGE) is a brain network disease, but the location of this network and its relevance for treatment remain unclear. We combine the locations of brain abnormalities in IGE (131 coordinates from 21 studies) with the human connectome to identify an IGE network. We validate this network by showing alignment with structural brain abnormalities previously identified in IGE and brain areas activated by generalized epileptiform discharges in simultaneous electroencephalogram-functional magnetic resonance imaging. The topography of the IGE network aligns with brain networks involved in motor control and loss of consciousness consistent with generalized seizure semiology. To investigate therapeutic relevance, we analyze data from 21 patients with IGE treated with deep brain stimulation (DBS) for generalized seizures. Seizure frequency reduced a median 90% after DBS and stimulation sites intersect an IGE network peak in the centromedian nucleus of the thalamus. Together, this study helps unify prior findings in IGE and identify a brain network target that can be tested in clinical trials of brain stimulation to control generalized seizures.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: M.D.F. serves as inventor on an active patent (US010137307B2) by Beth Israel Deaconess Medical Center that covers use of brain connectivity imaging to guide brain stimulation unrelated to the current work issued with no royalties and an active patent (US11666219B2) by Beth Israel Deaconess Medical Center that covers lesion network mapping (a precursor of coordinate network mapping used in this work) issued with no royalties. L.J.D. reports lecture fees for Boston Scientific. R.F. owns stock or options in Avails Medical, Cerebral Therapeutics, Eysz, Irody, Smart Monitor, and Zeto. A.H. reports lecture fees for Boston Scientific and is a consultant for FxNeuromodulation and Abbott. J.J. reports grants from the Research Council of Finland, Finnish Medical Foundation, Sigrid Juselius Foundation, Signe and Ane Gyllenberg Foundation, Finnish Foundation for Alcohol Studies, and Turku University Hospital; lecturer honoraria from Lundbeck and Novartis; travel support from Insightec, Abbvie, and Abbott, and consulting fees from Summaryx and Adamant Health; stocks of Neurologic Finland and Suomen Neurolaboratorio. E.H.M. serves as a consultant for Boston Scientific Corp, Olea Medical Inc., Varian Medical Systems Inc., and Cortechs.ai. Lecturer for Varian Medical Systems Inc. and Siemens Healthineers. Advisory Board member for Boston Scientific Corp and Varian Medical Systems Inc. The remaining authors declare no competing interests.
Figures
References
-
- Panayiotopoulos, C. P. (ed.) The Epilepsies: Seizures, Syndromes and Management (Bladon Medical Publishing, 2005). - PubMed
-
- Hirsch, E. et al. ILAE definition of the idiopathic generalized epilepsy syndromes: position statement by the ILAE task force on nosology and definitions. Epilepsia63, 1475–1499 (2022). - PubMed
-
- Vorderwulbecke, B. J., Wandschneider, B., Weber, Y. & Holtkamp, M. Genetic generalized epilepsies in adults - challenging assumptions and dogmas. Nat. Rev. Neurol.18, 71–83 (2022). - PubMed
-
- Jiang, T. et al. Drug-resistant idiopathic generalized epilepsy: a meta-analysis of prevalence and risk factors. Epilepsy Behav.146, 109364 (2023). - PubMed
-
- Zhang, Z. et al. Altered functional-structural coupling of large-scale brain networks in idiopathic generalized epilepsy. Brain134, 2912–2928 (2011). - PubMed
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
